Literature DB >> 4643692

Development of extremely attenuated live measles virus vaccine (CAM-EX).

S Ueda, M Takahashi, T Kurimura, Y Minekawa, N Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4643692

Source DB:  PubMed          Journal:  Biken J        ISSN： 0006-2324


× No keyword cloud information.
  6 in total

1.  Structural defect linked to nonrandom mutations in the matrix gene of biken strain subacute sclerosing panencephalitis virus defined by cDNA cloning and expression of chimeric genes.

Authors:  M Ayata; A Hirano; T C Wong
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

2.  Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus.

Authors:  T C Wong; M Ayata; S Ueda; A Hirano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Authors:  Y Murakami; T Seya; M Kurita; A Fukui; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.

Authors:  A Hirano
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.

Authors:  A Hirano; A H Wang; A F Gombart; T C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).

Authors:  T Seya; M Kurita; T Hara; K Iwata; T Semba; M Hatanaka; M Matsumoto; Y Yanagi; S Ueda; S Nagasawa
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.